|
Volumn 19, Issue 6, 2010, Pages 538-540
|
Long-term efficacy of etanercept in hidradenitis suppurativa: Results from an open-label phase II prospective trial
|
Author keywords
Etanercept; Hidradenitis suppurativa; Long term efficacy; Recurrence
|
Indexed keywords
ETANERCEPT;
ADOLESCENT;
ADULT;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DRUG EFFICACY;
FOLLOW UP;
HUMAN;
LETTER;
LONG TERM CARE;
OPEN STUDY;
PHASE 2 CLINICAL TRIAL;
PROSPECTIVE STUDY;
RECURRENT DISEASE;
REMISSION;
SUPPURATIVE HIDRADENITIS;
TREATMENT FAILURE;
TREATMENT RESPONSE;
ADOLESCENT;
ADULT;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
FEMALE;
FOLLOW-UP STUDIES;
HIDRADENITIS SUPPURATIVA;
HUMANS;
IMMUNOGLOBULIN G;
MALE;
MIDDLE AGED;
RECEPTORS, TUMOR NECROSIS FACTOR;
RECURRENCE;
REMISSION INDUCTION;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
|
EID: 77954081292
PISSN: 09066705
EISSN: 16000625
Source Type: Journal
DOI: 10.1111/j.1600-0625.2009.00967.x Document Type: Letter |
Times cited : (47)
|
References (19)
|